Antiallergic via inhibition of chemical mediator release from mast cells. Shown to be an effective inhibitor of angiogenesis. Demonstrated to antagonize the effects of angiotensin II on human arteries, possibly by an interaction at the level of the AT1 receptor. Inhibits TRPV2-mediated responses; binds to Aβ40 monomers and increases Aβ40 fibrillation.
|Storage||Store at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 327.34. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||3.05 mL||15.27 mL||30.55 mL|
|5 mM||0.61 mL||3.05 mL||6.11 mL|
|10 mM||0.31 mL||1.53 mL||3.05 mL|
|50 mM||0.06 mL||0.31 mL||0.61 mL|
References are publications that support the products' biological activity.
Hishikawa et al (1996) Tranilast restores cytokine-induced nitric oxide production against platelet derived growth factor in vascular smooth muscle cells. J.Cardiovasc.Pharmacol. 28 200 PMID: 8856474
Isaji et al (1997) Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo. Br.J.Pharmacol. 122 1061 PMID: 9401770
Jin et al (1998) Tranilast, an anti-allergic drug, possesses antagonistic potency to angiotensin II. Eur.J.Pharmacol. 361 199 PMID: 9865509
Hisanaga et al (2009) Regulation of calcium-permeable TRPV2 channel by insulin in pancreatic beta-cells. Diabetes. 58 174 PMID: 18984736
Connors et al (2013) Tranilast binds to Aβ monomers and promotes Aβ fibrillation. Biochemistry PMID: 23679559
If you know of a relevant reference for Tranilast, please let us know.
View Related Products by Target
Keywords: Tranilast, supplier, Anti-allergic, inhibits, inhibitors, release, mast, cells, Antiangiogenics, TRPV2, amyloid, beta, AB, monomers, alzheimers, amyloidbeta, amyloidb, amyloidβ, Miscellaneous, Compounds, Antiangiogenics, TRPV, Amyloid, Beta, Peptides, Miscellaneous, Compounds, Tocris Bioscience
Citations for Tranilast
Citations are publications that use Tocris products.
Currently there are no citations for Tranilast. Do you know of a great paper that uses Tranilast from Tocris? If so please let us know.
Average Rating:(Based on 0 Reviews)
Literature in this Area
New Product Guide (Spring/Summer 2017)New
Our new product guide highlights over 130 new products added to the Tocris Bioscience range during the first half of 2017.
- 7-TM Receptors
- Enzyme-Linked Receptors
- Ion Channels
- Nuclear Receptors
- Cell Metabolism
- Fluorescent Imaging
- Signal Transduction
- Stem Cells